Cargando…
Long COVID or post COVID-19 syndrome
Autores principales: | Lechner-Scott, J., Levy, M., Hawkes, C., Yeh, A., Giovannoni, G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8447548/ https://www.ncbi.nlm.nih.gov/pubmed/34601388 http://dx.doi.org/10.1016/j.msard.2021.103268 |
Ejemplares similares
-
COVID-19 vaccines and multiple sclerosis disease-modifying therapies
por: Giovannoni, Gavin, et al.
Publicado: (2021) -
Vaccine hesitancy in people with multiple sclerosis
por: Lechner-Scott, Jeannette S, et al.
Publicado: (2022) -
The COVID-19 pandemic and the use of MS disease-modifying therapies
por: Giovannoni, Gavin, et al.
Publicado: (2020) -
B cell therapy and the use of RNA-based COVID-19 vaccines
por: Vishnevetsky, Anastasia, et al.
Publicado: (2021) -
The Post-acute COVID-19 Syndrome (Long COVID)
por: Al-Jahdhami, Issa, et al.
Publicado: (2021)